1. Home
  2. BLRX vs TRUG Comparison

BLRX vs TRUG Comparison

Compare BLRX & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • TRUG
  • Stock Information
  • Founded
  • BLRX 2003
  • TRUG 1983
  • Country
  • BLRX Israel
  • TRUG United States
  • Employees
  • BLRX N/A
  • TRUG N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • BLRX Health Care
  • TRUG
  • Exchange
  • BLRX Nasdaq
  • TRUG NYSE
  • Market Cap
  • BLRX 12.1M
  • TRUG 8.4M
  • IPO Year
  • BLRX 2011
  • TRUG N/A
  • Fundamental
  • Price
  • BLRX $5.25
  • TRUG $0.24
  • Analyst Decision
  • BLRX Strong Buy
  • TRUG Strong Buy
  • Analyst Count
  • BLRX 2
  • TRUG 1
  • Target Price
  • BLRX $19.00
  • TRUG $2.00
  • AVG Volume (30 Days)
  • BLRX 1.9M
  • TRUG 8.4M
  • Earning Date
  • BLRX 05-27-2025
  • TRUG 05-15-2025
  • Dividend Yield
  • BLRX N/A
  • TRUG N/A
  • EPS Growth
  • BLRX N/A
  • TRUG N/A
  • EPS
  • BLRX N/A
  • TRUG N/A
  • Revenue
  • BLRX $22,340,000.00
  • TRUG $22,236,072.00
  • Revenue This Year
  • BLRX N/A
  • TRUG $24.05
  • Revenue Next Year
  • BLRX N/A
  • TRUG $31.65
  • P/E Ratio
  • BLRX N/A
  • TRUG N/A
  • Revenue Growth
  • BLRX 91.68
  • TRUG 8.40
  • 52 Week Low
  • BLRX $2.30
  • TRUG $0.17
  • 52 Week High
  • BLRX $35.60
  • TRUG $1.52
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 84.90
  • TRUG 46.22
  • Support Level
  • BLRX $3.32
  • TRUG $0.20
  • Resistance Level
  • BLRX $3.97
  • TRUG $0.42
  • Average True Range (ATR)
  • BLRX 0.46
  • TRUG 0.05
  • MACD
  • BLRX 0.14
  • TRUG 0.00
  • Stochastic Oscillator
  • BLRX 47.06
  • TRUG 25.14

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: